  Defining determinants of broadly neutralizing antibody evolution in viral infection to guide vaccine development  
Building on recent discoveries in the HIV antibody field, we will conduct a systematic screen for broadly neutralizing antibody activity elicited during HIV infection using the extensive sample and data collection of the Swiss HIV Cohort Study and the Zurich Primary HIV Infection study. 
